6-bromo-7H-purine | CAS:767-69-1

We serve 6-bromo-7H-purine CAS:767-69-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
6-bromo-7H-purine

Chemical Name:6-bromo-7H-purine
CAS.NO:767-69-1
Synonyms:Purine,6-bromo
6-bromo-9H-purine
6-Bromopurine
6-Brom-purin
Molecular Formula:C5H3BrN4
Molecular Weight:199.00800
 
Physical and Chemical Properties:
Density:2.036
Melting point:>300ºC
Boiling point:472.8ºC
Index of Refraction:1.767
 
Specification:
Appearance:White to yellow powder
Assay(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of idelalisib.



Contact us for information like 6-bromo-7H-purine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Brom-purin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Purine,6-bromo Use and application,6-Bromopurine technical grade,usp/ep/jp grade.


Related News: As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured.1,4-Dimethoxybenzene manufacturer The Shanghai Institute of Materia Medica is under the Chinese Academy of Sciences (CAS), a top government think tank. The Wuhan Institute of Virology is also administered by the CAS and is among the country’s most advanced virus research laboratories.3-Methyl-1-(4-sulfophenyl)-2-pyrazolin-5-one supplier The Shanghai Institute of Materia Medica is under the Chinese Academy of Sciences (CAS), a top government think tank. The Wuhan Institute of Virology is also administered by the CAS and is among the country’s most advanced virus research laboratories.1-bromobut-2-yne vendor The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.